Last 86,200 KRW
Change Today -800.00 / -0.92%
Volume 5.0K
000070 On Other Exchanges
Symbol
Exchange
Korea SE
Korea SE
As of 1:22 AM 03/6/15 All times are local (Market data is delayed by at least 15 minutes).

samyang holdings corp (000070) Snapshot

Open
86,700
Previous Close
87,000
Day High
87,400
Day Low
86,200
52 Week High
01/28/15 - 99,000
52 Week Low
03/20/14 - 65,900
Market Cap
738.2B
Average Volume 10 Days
5.2K
EPS TTM
-4,368.00
Shares Outstanding
8.6M
EX-Date
12/29/14
P/E TM
--
Dividend
1,500
Dividend Yield
1.74%
Current Stock Chart for SAMYANG HOLDINGS CORP (000070)

Related News

No related news articles were found.

samyang holdings corp (000070) Related Businessweek News

No Related Businessweek News Found

samyang holdings corp (000070) Details

Samyang Holdings Corporation, through its subsidiaries, is engaged in chemicals, foodstuffs, pharmaceuticals, and other businesses in South Korea. Its Chemical business produces and sells chemical products that include high-value-added materials, terephthalic acid, polycarbonate resin, and bisphenol-A. The company’s Foodstuff business produces and sells brownie and ice cream mixes; glucose, starch syrup, starch, sorbitol, maltitol, and oligosaccharides to foodstuff, pharmaceutical, papermaking, texture, and cosmetics industries; flour and premixes; and fructose to Coca Cola, Pepsi Cola, and other carbonated-beverage makers, as well as to Chinese beverage manufacturers. This business also operates a restaurant under the Seven Springs name, as well as a bakery café under the Mix & Bake name. Its Pharmaceutical business develops and sells anti-cancer drugs, such as Genexol PM and Nanoxel PM; NicoStop, a smoking cessation patch; and Trisorb and Monosorb that are biodegradable sutures. This business also exports its products to North America, as well as to South America. Its Independent business is involved in manufacturing paper making machines; the operation of pure-water manufacturing and wastewater treatment facilities; and the provision of IT services, such as IT consulting on system management and integration, and e-business to a range of sectors, including foodstuff, chemicals, drugs, industrial fibers, environment, trade, and food service. Samyang Holdings Corporation was founded in 1924 and is based in Seoul, South Korea.

Founded in 1924

samyang holdings corp (000070) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

samyang holdings corp (000070) Key Developments

Samyang Holdings Corporation Proposes Amendments to its Articles of Incorporation

Samyang Holdings Corporation proposed amendments to its articles of incorporation to its shareholders meeting to be held on March 27, 2015.

Samyang Holdings Corporation, Annual General Meeting, Mar 21, 2014

Samyang Holdings Corporation, Annual General Meeting, Mar 21, 2014., at 10:30 Korea Standard Time. Location: first floor auditorium Jongno-gu. Agenda: To consider the group financial statements (including the statement of retained earnings) and approval of the consolidated financial statements; to consider the election of Directors; and to approve the director remuneration.

Sorrento Therapeutics Acquires the Exclusive Rights to Cynviloq to Expand into Australia, Canada and Mexico

Sorrento Therapeutics Inc. announced that it has acquired the exclusive rights to Cynviloq in Australia, Canada and Mexico from Samyang Biopharmaceuticals, a South Korean corporation. Sorrento has the exclusive rights to Samyang's Cynviloq (marketed as Genexol-PM in South Korea and other countries) in the US and the 27 countries of the EU. According to the company, Cynviloq (IG-001; a paclitaxel-loaded micellar diblock copolymer) is a next-generation branded paclitaxel formulation for the potential treatment of metastatic breast cancer, non-small cell lung cancer, pancreatic cancer and other solid tumors.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000070:KS 86,200.00 KRW -800.00

000070 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000070.
View Industry Companies
 

Industry Analysis

000070

Industry Average

Valuation 000070 Industry Range
Price/Earnings 44.7x
Price/Sales 0.3x
Price/Book 0.5x
Price/Cash Flow 28.1x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAMYANG HOLDINGS CORP, please visit www.samyang.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.